
This article explains the 4 shifts enabling faster, lower-risk, commercially successful biologics technology transfer.
Jim Miller, President of PharmSource, speaks with Pharmaceutical Technology.
Jim Miller, President of PharmSource, spoke with Pharmaceutical Technology about the contract services market, and CMO acquisition activity.






